ISPOR 2022
Oxford University Innovation's Clinical Outcome team will be attending the annual ISPOR 2022 conference in Washington, DC, USA from the 15th - 18th May 2022.
PDQ-39 used to evaluate Health-Related Quality of Life in randomized controlled trial that uses DBS system to treat patients with Parkinson’s disease
Patients were implanted bilaterally with Boston Scientific’s FDA-approved Vercise Genus DBS system. During long-term follow-up, quality of life was evaluated using the Parkinson’s Disease Questionnaire (PDQ-39).
Measure the quality of patient recovery following surgery & anaesthesia with real-time feedback through the use of PostopQRS™
A new web-based digital e(COA) tool now available from the Clinical Outcomes team at Oxford University Innovation.
Generate QALY’s for use in analysis of mental healthcare interventions
Recovering Quality of Life - Utility Index now available! Health economists can now build Quality-Adjusted Life Year (QALY) evidence in support of their mental healthcare interventions.
The 14th UK Stroke Forum Conference
The Clinical Outcomes team at Oxford University Innovation will be supporting Prof. Nele Demeyere and her team at the 14th UK Stroke Forum conference from the 3rd to the 5th December, Telford.
Isis Outcomes and Oxford Health Outcomes experts present at eCOA 2014
The eCOA Forum brings together world leaders in PRO development and health outcomes.
© Oxford University Innovation